Videos

Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.

Back in the spotlight: Exploring echocardiography's revival

American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.

Roberto Lang, MD, explains how AI can help novice users get diagnostic quality cardiac echo exams at ASE 2023.#ASE #AI #ASE2023

AI can help novice sonographers deliver optimal echocardiograms

Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 

Ted Abraham, MD, explains ASE efforts to increase HCM education and standardization of care. #HCM #ASE #ASE23 #ASE2023

All eyes are on hypertrophic cardiomyopathy now that a drug treatment is in place

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

James Kirkpatrick, MD, explains the key trends at ASE 2023. #ASE23 #ASE2023

Key takeaways in cardiac ultrasound from ASE 2023

James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.

The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment.

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

Video of Jon Lindner explaining the use of ultrasound and bubble contrast for therapy.

Cardiac ultrasound could lead to key advances in heart attack care, drug delivery

Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.

Malissa Wood, MD. explains why Mass General created a program to combat racism and health equity.

Why health equity is important in cardiology

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

Malissa J. Wood, MD, associate chief of cardiology for diversity and equity, and co-director, Corrigan Women’s Heart Health Program, Massachusetts General Hospital, spoke with Cardiovascular Business to explains some of the latest data from the iSCAD Registry presented at the American College of Cardiology 2023 meeting. She also discussed how these patients are currently diagnosed and and managed. #SCAD

Management of patients with SCAD

Malissa Wood, MD, co-director of Corrigan Women’s Heart Health Program at Massachusetts General Hospital, shares some of the latest data from the iSCAD Registry.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.